Felix Ruebel

Home dialysis with a new feeling of security PeriSafe® is a novel device for peritoneal dialysis patients. We integrated patient's feedback, eye-tracking and usability engineering to develop a device that supports all patients who wish to stay independent. Our product generates value for the entire healthcare system, above all the patient, but also the healthcare providers and insurances. PeriSafe® is the first system, that connects the transfer set and dialysis tubing within a closed device, without manual contact of the patient with the open transfer set. Manual handling of clamps and breaking the frangible is replaced by simply pushing a button. It is a connection device that will make home dialysis easier and safer for elderly patients. About the company Peripal AG is an ETH start-up developing medical devices to facilitate dialysis. The company is based in Zurich and has closed a Series B Financing Round. Home Care is paramount to manage costs and productivity in the future healthcare markets. The vision of Peripal AG is to allow more patients to be treated at home and to reduce healthcare costs in the area of dialysis. The current market volume of home peritoneal dialysis is $ 3.2bn and it is forecasted to grow at 6% annually until 2025, driven by age, diabetes, and hypertension. Contact: info@peripal.com

Home dialysis with a new feeling of security PeriSafe® is a novel device for peritoneal dialysis patients. We integrated patient's feedback, eye-tracking and usability engineering to develop a device that supports all patients who wish to stay independent. Our product generates value for the entire healthcare system, above all the patient, but also the healthcare providers and insurances. PeriSafe® is the first system, that connects the transfer set and dialysis tubing within a closed device, without manual contact of the patient with the open transfer set. Manual handling of clamps and breaking the frangible is replaced by simply pushing a button. It is a connection device that will make home dialysis easier and safer for elderly patients. About the company Peripal AG is an ETH start-up developing medical devices to facilitate dialysis. The company is based in Zurich and has closed a Series B Financing Round. Home Care is paramount to manage costs and productivity in the future healthcare markets. The vision of Peripal AG is to allow more patients to be treated at home and to reduce healthcare costs in the area of dialysis. The current market volume of home peritoneal dialysis is $ 3.2bn and it is forecasted to grow at 6% annually until 2025, driven by age, diabetes, and hypertension. Contact: info@peripal.com

Claves Investments is a promoter of entrepreneurship and supports carefully selected young companies and startup companies in the search for private investors and for private venture capital. Claves Investments team members bring experience as C-level executives and directors from a variety of industries. They also invest as individual shareholders in selected companies.